CAPE TOWN - South Africa’s medicines regulator said on Thursday that it was at an advanced stage of reviewing an emergency use application for Pfizer’s COVID-19 vaccine.
A Section 21 application, normally valid for six months, is an instrument for emergency use access of a health product that is unregistered. AstraZeneca’s COVID-19 vaccine was granted Section 21 approval by SAHPRA in January. South Africa, the hardest-hit by the pandemic on the African continent in terms of recorded infections and deaths, hopes to receive 117,000 Pfizer doses before the end of the month from global vaccine distribution scheme COVAX.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.